VPS13A Disease (Chorea‐Acanthocytosis) in Puerto Rico; New Genetic and Clinical Observations
Authors:
- Cristal Alicea‐MalaveCACristal Alicea‐Malave
- Antonio Velayos‐BaezaAVAntonio Velayos‐Baeza
- Sylvette Ayala‐PeñaSASylvette Ayala‐Peña
- Laura Surillo‐DahdahLSLaura Surillo‐Dahdah
- Carmen SerranoCSCarmen Serrano
- Matthew J. BarrettMBMatthew J. Barrett
- Sara E. BermanSBSara E. Berman
- Alessandro Di RoccoARAlessandro Di Rocco
- Kevin M. FlaniganKFKevin M. Flanigan
- Mitesh LotiaMLMitesh Lotia
- 16 October 2026
- journal article
- Published by Wiley in Movement Disorders Clinical Practice
Abstract
Background: VPS13A disease is a very rare neurodegenerative disorder caused by mutations in the VPS13A gene. Its prevalence appears to be relatively high in Puerto Ricans, although limited genetic information has been available. Objectives: To describe the genetics of VPS13A disease (chorea‐acanthocytosis) in Puerto Rico. Methods: Data were obtained from Puerto Rican patients with genetically confirmed VPS13A disease. Results: Eighteen cases were identified, all carrying at least one of four mutations, c.1400_1401del, c.3556_3557dup, c.3889C>T, and c.2825‐253_2905‐374del (exon_27‐deletion); six additional single variants were detected. Seizures were the presenting symptom in 53% of patients. Conclusion: The presence of these probable founder mutations could explain the apparently increased prevalence in Puerto Rico; half of the described variants are newly described mutations and half have been previously reported. Enhanced clinical awareness of the spectrum of presenting symptoms and diagnostic clues, and improved access to genetic testing are essential for timely diagnosis in this population.Keywords
This publication has 20 references indexed in Scilit:
- Clinico-genetic profile of case series of six Tamilian chorea-acanthocytosis families with VPS13A mutations from South IndiaParkinsonism & Related Disorders, 2025
- An Autopsy Series of Seven Cases of VPS13A Disease (Chorea‐Acanthocytosis)Movement Disorders, 2023
- Sphingolipid and Phospholipid Levels Are Altered in Human Brain in Chorea‐AcanthocytosisMovement Disorders, 2023
- Phenomenology and disease progression of chorea-acanthocytosis patients in SpainParkinsonism & Related Disorders, 2018
- Genetic diagnosis of neuroacanthocytosis disorders using exome sequencingMovement Disorders, 2011
- Novel pathogenic mutations and copy number variations in the VPS13A Gene in patients with chorea‐acanthocytosisAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2011
- Choreoacanthocytosis in a Mexican FamilyArchives of Neurology, 2007
- Identification of a VPS13A founder mutation in French Canadian families with chorea-acanthocytosisneurogenetics, 2005
- Testing for acanthocytosisJournal of Neurology, 2005
- Chorein detection for the diagnosis of chorea‐acanthocytosisAnnals of Neurology, 2004